Na Li

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Cognitive Impairment

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Molecular biology reports

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Sitong Ming, Mo Kan, Liu Liu, Zhuang Zhang, Xiaoran Liu, Yaxin Liu, Zhen Li, Yanhong Zhang, Qihang Pang, Jianan Lin, Hui Li, Qing Yang, Xin Sui, Xiaobo Qu, Na Li
Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Zhanhong Cao, Jianheng Pan, Xin Sui, Chunqiu Fang, Na Li, Xiaowei Huang, Xiaobo Qu, Dong Han
Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Jifeng Wang, Min He, Wenjun Guo, Yanhong Zhang, Xin Sui, Jianan Lin, Xiaoran Liu, Hui Li, Jing Li, Qing Yang, Mo Kan, Zhuang Zhang, Sitong Ming, Xiaobo Qu, Na Li
Microbiome-Metabolomics Reveals Endogenous Alterations of Energy Metabolism by the Dushen Tang to Attenuate D-Galactose-Induced Memory Impairment in Rats. BioMed research international 2021 (2021)
Xijun Chen, Hui Li, Qing Yang, Xingcheng Lan, Jifeng Wang, Zhanhong Cao, Xiaozheng Shi, Jing Li, Mo Kan, Xiaobo Qu, Na Li
Ginsenoside compound K ameliorates Alzheimer's disease in HT22 cells by adjusting energy metabolism. Molecular biology reports 46 (5) (2019)